Cell differentiation not only results in the production of specific molecules for differentiated functions, but is accompanied by concomitant alterations in other cellular phenotypes including cell morphology and cell behavior (4,6,7,12). This also seems to be the case for the suppression of differentiated functions. For instance, when melanoma cells are treated with 5-bromodeoxyuridine (BrdU), their differentiated marker, melanin synthesis, is suppressed, and such transformed phenotypes as tumorigenicity, plasminogen activator production and cell-to-substratum adhesiveness are concurrently modified (2, 15). How these alterations in the various cellular phenotypes cause the expression or suppression of differentiated functions is not clear.In the present study, we isolated tyrosinase-negative variants which appeared spontaneously in a cultured melanotic B16 mouse melanoma cell strain and compared them with tyrosinase-positive cell lines obtained from the same cell strain. The variants were characterized by their melanogenic ability. We used other cellular phenotypes including cell morphology, anchorage dependency and cell-to-substratum adhesiveness to examine whether any significant relationship between the loss or expression of differentiated functions and the alteration of transformed phenotypes Abbreviations:BrdU, 5-bromodeoxyuridine; DOC, sodium desoxycholate; OD, optical density; DOPA, 3,4-dihydroxyphenylalanine.199